Literature DB >> 17304645

Rheumatoid arthritis and lymphoma: risky business for B cells.

Gordon Starkebaum.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17304645

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

1.  Spontaneous regression of EBV-associated diffuse lymphoproliferative disease in a patient with rheumatoid arthritis after discontinuation of etanercept treatment.

Authors:  Sung-Hoon Park; Chae-Gi Kim; Ji-Young Kim; Jung-Yoon Choe
Journal:  Rheumatol Int       Date:  2007-10-18       Impact factor: 2.631

2.  Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program.

Authors:  Xavier Mariette; Connie Chen; Pinaki Biswas; Kenneth Kwok; Mary G Boy
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-04-02       Impact factor: 4.794

3.  A Putative Case of Methotrexate-Related Lymphoma: Clinical Course and PET/CT Findings.

Authors:  Rachel C Jankowitz; James Ganon; Todd Blodgett; Christine Garcia; Samuel Jacobs
Journal:  Case Rep Med       Date:  2009-12-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.